Charles River Laboratories International Inc.
CRL
Market Cap$5.21B
Close$
$174.28
63.1% upside
Current Fair Value
63.1% upsideUndervalued by 63.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.21 Billion |
|---|---|
| Enterprise Value | $7.99 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.67 |
| Beta | 1.45 |
| Outstanding Shares | 51,138,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 442.75 |
|---|---|
| PEG | -206.65 |
| Price to Sales | 1.35 |
| Price to Book Ratio | 1.57 |
| Enterprise Value to Revenue | 1.97 |
| Enterprise Value to EBIT | 59.04 |
| Enterprise Value to Net Income | 603 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 0.86 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Charles River Laboratories International Inc.
17,000 employees
CEO: James Foster Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our...